PURPOSE: To examine how patients categorize their pain with the two commonly employed scales. METHODS AND MATERIALS: Patients with bone metastases referred to an outpatient palliative radiotherapy clinic were asked to rate their current pain on a numerical scale of 0-10 (0 = no pain, 10 = worst pain possible) and a categorized scale: none, mild, moderate and severe. RESULTS: Two hundred and seventeen patients were enrolled in the study. The median age was 66 years and median Karnofsky Performance Score was 70. The most common primary cancer sites were lung, prostate and breast. Based on patient-evaluated symptoms, 60% of patients who categorized pain as mild assigned it a 3 (24%) or 4 (36%), 63% who categorized pain as moderate assigned it a 5 (16.9%), 6 (19.1%) or 7 (27%) and 80% who categorized pain as severe assigned it an 8 (28.2%), 9 (12.6%) or 10 (39.8%). CONCLUSION: Our patients scored pain as mild if pain was < or =4, moderate if pain was 5-7 and severe if pain was > or =8.
PURPOSE: To examine how patients categorize their pain with the two commonly employed scales. METHODS AND MATERIALS: Patients with bone metastases referred to an outpatient palliative radiotherapy clinic were asked to rate their current pain on a numerical scale of 0-10 (0 = no pain, 10 = worst pain possible) and a categorized scale: none, mild, moderate and severe. RESULTS: Two hundred and seventeen patients were enrolled in the study. The median age was 66 years and median Karnofsky Performance Score was 70. The most common primary cancer sites were lung, prostate and breast. Based on patient-evaluated symptoms, 60% of patients who categorized pain as mild assigned it a 3 (24%) or 4 (36%), 63% who categorized pain as moderate assigned it a 5 (16.9%), 6 (19.1%) or 7 (27%) and 80% who categorized pain as severe assigned it an 8 (28.2%), 9 (12.6%) or 10 (39.8%). CONCLUSION: Our patients scored pain as mild if pain was < or =4, moderate if pain was 5-7 and severe if pain was > or =8.
Authors: Edward Chow; Keyue Ding; Wendy R Parulekar; Rebecca K S Wong; Yvette M van der Linden; Daniel Roos; William F Hartsell; Peter Hoskin; Jackson S Y Wu; Abdenour Nabid; Francisca Ong; Geertjan van Tienhoven; Scott Babington; William F Demas; Carolyn F Wilson; Michael Brundage; Liting Zhu; Ralph M Meyer Journal: Support Care Cancer Date: 2015-09-23 Impact factor: 3.603
Authors: Ethan Basch; Xiaoyu Jia; Glenn Heller; Allison Barz; Laura Sit; Michael Fruscione; Mark Appawu; Alexia Iasonos; Thomas Atkinson; Shari Goldfarb; Ann Culkin; Mark G Kris; Deborah Schrag Journal: J Natl Cancer Inst Date: 2009-11-17 Impact factor: 13.506
Authors: Judith M Schlaeger; Kevin C Cain; Erin K Myklebust; Keesha L Powell-Roach; Brenda W Dyal; Diana J Wilkie Journal: Pain Date: 2020-02 Impact factor: 6.961
Authors: Judith A Paice; Matt Mulvey; Michael Bennett; Patrick M Dougherty; John T Farrar; Patrick W Mantyh; Christine Miaskowski; Brian Schmidt; Thomas J Smith Journal: J Pain Date: 2016-11-21 Impact factor: 5.820